To achieve its function in the treatment of hypertension, fosinoprilat inhibits the conversion of the decapeptide angiotensin I (proangiotensin) to the octapeptide angiotensin II, a key component of the renin-angiotensin-aldosterone system (RAAS). This evidence concerns the gene REN and Hypertension.